NO990792L - FremgangsmÕte for inhibering av ekspresjonen av FAS - Google Patents

FremgangsmÕte for inhibering av ekspresjonen av FAS

Info

Publication number
NO990792L
NO990792L NO990792A NO990792A NO990792L NO 990792 L NO990792 L NO 990792L NO 990792 A NO990792 A NO 990792A NO 990792 A NO990792 A NO 990792A NO 990792 L NO990792 L NO 990792L
Authority
NO
Norway
Prior art keywords
fas
inhibiting
expression
Prior art date
Application number
NO990792A
Other languages
English (en)
Norwegian (no)
Other versions
NO990792D0 (no
Inventor
Giora Zeev Feuerstein
Tian-Li Yue
Original Assignee
Boehringer Mannheim Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp
Publication of NO990792D0 publication Critical patent/NO990792D0/no
Publication of NO990792L publication Critical patent/NO990792L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
NO990792A 1996-08-23 1999-02-19 FremgangsmÕte for inhibering av ekspresjonen av FAS NO990792L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2448696P 1996-08-23 1996-08-23
PCT/US1997/014792 WO1998007321A1 (en) 1996-08-23 1997-08-22 Method for inhibiting the expression of fas

Publications (2)

Publication Number Publication Date
NO990792D0 NO990792D0 (no) 1999-02-19
NO990792L true NO990792L (no) 1999-04-15

Family

ID=21820837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990792A NO990792L (no) 1996-08-23 1999-02-19 FremgangsmÕte for inhibering av ekspresjonen av FAS

Country Status (17)

Country Link
US (1) US6096777A (ko)
EP (1) EP0924985A4 (ko)
JP (1) JP2001504804A (ko)
KR (1) KR20000068322A (ko)
CN (1) CN1233150A (ko)
AU (1) AU4083097A (ko)
BR (1) BR9711228A (ko)
CA (1) CA2264178A1 (ko)
CZ (1) CZ59199A3 (ko)
HU (1) HUP9904243A3 (ko)
IL (1) IL128613A (ko)
NO (1) NO990792L (ko)
NZ (1) NZ334307A (ko)
PL (1) PL331766A1 (ko)
TR (1) TR199900370T2 (ko)
WO (1) WO1998007321A1 (ko)
ZA (1) ZA977565B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20050148779A1 (en) * 2002-04-30 2005-07-07 Wei Chen Carvedilol monocitrate monohydrate
CA2492084A1 (en) * 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydobromide
CN1678305A (zh) * 2002-06-27 2005-10-05 Sb药物波多黎各公司 卡维地洛磷酸盐和/或其溶剂合物和/或相应组合物和/或治疗方法
US6632832B1 (en) 2002-09-10 2003-10-14 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
AU2002336473A1 (en) * 2002-09-10 2004-04-30 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
WO2005051383A1 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US20050175695A1 (en) * 2003-11-25 2005-08-11 Catherine Castan Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
ZA200803226B (en) 2005-10-13 2009-11-25 Orchid Res Lab Ltd Heterocyclic Compounds as Pstat3/IL-6 Inhibitors
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5393772A (en) * 1993-11-24 1995-02-28 Boehringer Mannheim Pharmaceuticals Corporation Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation

Also Published As

Publication number Publication date
EP0924985A4 (en) 2000-12-06
CZ59199A3 (cs) 1999-08-11
HUP9904243A3 (en) 2001-09-28
TR199900370T2 (xx) 1999-05-21
NZ334307A (en) 2000-11-24
JP2001504804A (ja) 2001-04-10
NO990792D0 (no) 1999-02-19
HUP9904243A2 (hu) 2000-05-28
PL331766A1 (en) 1999-08-02
WO1998007321A1 (en) 1998-02-26
CN1233150A (zh) 1999-10-27
KR20000068322A (ko) 2000-11-25
AU4083097A (en) 1998-03-06
IL128613A0 (en) 2000-01-31
BR9711228A (pt) 2000-01-11
US6096777A (en) 2000-08-01
IL128613A (en) 2004-07-25
EP0924985A1 (en) 1999-06-30
CA2264178A1 (en) 1998-02-26
ZA977565B (en) 1999-02-17

Similar Documents

Publication Publication Date Title
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO983405L (no) Fremgangsmåte for ökning av smöreevnen til snöskigrunnflater
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
FI965268A (fi) Menetelmä moniarvoisten alkoholien valmistamiseksi
ID20637A (id) Metode untuk menghambat pembentukan sulfida biogenik
NO971213L (no) Fremgangsmåte for modellering av beliggenheten av diskontinuiteter
NO990792L (no) FremgangsmÕte for inhibering av ekspresjonen av FAS
FI973095A (fi) Menetelmiä ympäristöestrogeenien estämiseksi
NL1001588C2 (nl) Werkwijze en stelsel ter voorkoming van de vorming van hydraten.
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FI981803A0 (fi) Menetelmä saostumien muodostumisen estämiseksi
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
UA25365A (uk) Спосіб профілактики вториhhої катаракти
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
UA25353A (uk) Спосіб холецистостомії
NO960391L (no) Fremgangsmåte for utvinning av fiskemel
FI963726A0 (fi) Foerfarande foer anordnande av en transaktionsbaserad faktvering i samband med telefontjaenster
SE9300381D0 (sv) Foerfaringssaett vid desinficering av vatten
FI963656A0 (fi) Foerverkligande av audiokorrektorer med warpade digitalfiltrer
FI964352A0 (fi) Rengoering av en plattvaermevaexlare med hjaelp av effektultraljud
FI963490A0 (fi) Foerbaettring av gasblandningen en cellforming foerbraenningsskaol med passagefront
UA25745A (uk) Спосіб виготовлеhhя аhода
UA25134A (uk) Спосіб моделюваhhя гhійhо-hекротичhого паhкреатиту
FIU950441U0 (fi) Glasfoeremaol med bihang av metalltraod

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application